Ultralife Corporation (ULBI) Receives Coverage Optimism Score of 0.10
Press coverage about Ultralife Corporation (NASDAQ:ULBI) has been trending somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Ultralife Corporation earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave news coverage about the technology company an impact score of 46.5891214535235 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Ultralife Corporation (ULBI) remained flat at $6.35 during midday trading on Friday. 7,392 shares of the stock were exchanged. Ultralife Corporation has a 52 week low of $3.76 and a 52 week high of $7.65. The firm has a market cap of $98.76 million, a P/E ratio of 18.09 and a beta of -0.16. The stock’s 50-day moving average is $6.85 and its 200-day moving average is $6.17.
Ultralife Corporation (NASDAQ:ULBI) last released its earnings results on Thursday, August 3rd. The technology company reported $0.07 earnings per share for the quarter. The company had revenue of $19.94 million during the quarter. Ultralife Corporation had a return on equity of 7.94% and a net margin of 6.62%. On average, equities analysts predict that Ultralife Corporation will post $0.06 EPS for the current year.
Ultralife Corporation Company Profile
Ultralife Corporation offers products and services ranging from power solutions to communications and electronics systems. The Company designs and manufactures power and communications systems, including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom engineered systems.
Receive News & Stock Ratings for Ultralife Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife Corporation and related stocks with our FREE daily email newsletter.